Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency

2008/08/16 by Bangning Yu, Jaime Becnel, Mourad Zerfaoui +3 · 215 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · Psychology · #Agonist #Biology #Chemistry #Endocrinology #Immunology #Inflammation #Internal medicine #Medicine #Nicotinic Acetylcholine Receptors Study #Pharmacology #Proinflammatory cytokine #Psychedelics and Drug Studies #Receptor #Receptor Mechanisms and Signaling #Serotonin #Tumor necrosis factor alpha

paper · doi:10.1124/jpet.108.143461

published in Journal of Pharmacology and Experimental Therapeutics 327(2), 316-323 (American Society for Pharmacology and Experimental Therapeutics)

openalex publication_date 2008/08/16 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/01

Citations

• Functional Selectivity and Classical Concepts of Quantitative Pharmacology
• The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Cited by

• Psychedelics as potent anti-inflammatory therapeutics
• Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs
• Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
• Psychedelics
• Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
• Serotonin attenuates tumor necrosis factor-induced intestinal inflammation by interacting with human mucosal tissue
• Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT 2A receptor psychedelics from a transdiagnostic perspective
• Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration
• Serotonergic Mechanisms as Targets for Existing and Novel Antipsychotics
• Depression: an inflammatory illness?: Figure 1
• Reflex control of immunity. [europepmc]
• Serotonin 5-HT2A receptor activation blocks TNF-α mediated inflammation in vivo. [europepmc]
• Maternal hematopoietic TNF, via milk chemokines, programs hippocampal development and memory. [europepmc]
• Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus. [europepmc]
• Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. [europepmc]
• Return of the lysergamides. Part II: Analytical and behavioural characterization of N 6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ). [europepmc]
• Clinical applications of hallucinogens: A review. [europepmc]
• Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice. [europepmc]
• The Effects of Serotonin in Immune Cells. [europepmc]
• Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. [europepmc]
• Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process. [europepmc]
• A New Venue of TNF Targeting. [europepmc]
• Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. [europepmc]
• Activation of 5-HT 2 Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice. [europepmc]
• Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour. [europepmc]
• Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. [europepmc]
• Critical Neurotransmitters in the Neuroimmune Network. [europepmc]
• Pivotal mental states. [europepmc]
• Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore. [europepmc]
• Inflammatory signaling mechanisms in bipolar disorder. [europepmc]
• Psychedelic-inspired approaches for treating neurodegenerative disorders. [europepmc]
• Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective. [europepmc]
• Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies. [europepmc]
• Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders. [europepmc]
• Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. [europepmc]